A Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Therapy in Subjects With Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7)
收藏DataMed2026-07-14 收录
官方服务：
资源简介：
The primary objective of the study is to evaluate the long-term safety of UX003 in subjects with MPS 7.
提供机构：
ClinicalTrials.gov
